ArticleBlood advances2025

Venetoclax-proteasome inhibitor-dexamethasone for unfit patients with blastic plasmacytoid dendritic cell neoplasm.

Sabine Khalife-Hachem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.